Connor, Clark & Lunn Investment Management »

Anavex Life Sciences shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of Anavex Life Sciences (AVXL) shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in Anavex Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Anavex Life Sciences held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anavex Life Sciences by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $60k 20k 3.07
2022-09-30 $1000k 97k 10.32
2022-06-30 $169k 17k 9.99

More positions owned by Connor, Clark & Lunn Investment Management

Rbc Cad (RY)
Agnico (AEM)
Toronto Dominion Bk Ont Com New (TD)
Suncor Energy (SU)
Enbridge (ENB)
NVIDIA Corporation (NVDA)
Cibc Cad (CM)
Tc Energy Corp (TRP)
Apple (AAPL)
Shopify Cl A Sub Vtg Shs (SHOP)
Bk Nova Cad (BNS)
Invesco Exch Traded Fd Tr Ii Purbta Msci Us (PBUS)
Canadian Pacific Kansas City (CP)
Microsoft Corporation (MSFT)
Amazon (AMZN)

View all positions for Connor, Clark & Lunn Investment Management

Top funds holding Anavex Life Sciences

BlackRock
Vanguard Group
State Street Corporation
Vanguard Capital Management
Two Sigma Investments
Geode Capital Management
Susquehanna International
Citadel Advisors
Summit Financial
Bank of America Corporation
Goldman Sachs Group
Vanguard Portfolio Management
AQR Capital Management
Charles Schwab Investment Management
Northern Trust

View all funds holding Anavex Life Sciences